======= ZBTB2 =======
== Gene Information ==
* **Official Symbol**: ZBTB2
* **Official Name**: zinc finger and BTB domain containing 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57621|57621]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8N680|Q8N680]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ZBTB2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZBTB2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616595|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: May be involved in transcriptional regulation.
|BTB|
|DNA-binding transcription repressor activity, RNA polymerase II-specific|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|negative regulation of transcription by RNA polymerase II|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp124|GSK343 3μM R03 exp124]]|-2.95|
|[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-1.75|
|[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|-1.7|
|[[:results:exp75|MK-1775 0.32μM R02 exp75]]|1.73|
|[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.8|
|[[:results:exp416|Tubacin 1.6μM R07 exp416]]|1.8|
|[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.93|
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.99|
|[[:results:exp180|Dynasore 10μM R04 exp180]]|2|
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.25|
|[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.48|
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|2.77|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2403
* **Expression level (log2 read counts)**: 5.09
{{:chemogenomics:nalm6 dist.png?nolink |}}